View Item 

Show simple item record

Management of kostmann syndrome in the g-csf era
dc.contributor.authorZeidler, Corneliaen_US
dc.contributor.authorBoxer, Laurence A.en_US
dc.contributor.authorDale, David C.en_US
dc.contributor.authorFreedman, M. H.en_US
dc.contributor.authorKinsey, Sallyen_US
dc.contributor.authorWelte, K.en_US
dc.date.accessioned2010-06-01T20:55:00Z
dc.date.available2010-06-01T20:55:00Z
dc.date.issued2000-06en_US
dc.identifier.citationZeidler, C.; Boxer, L.; Dale, D. C.; Freedman, M. H.; Kinsey, S.; Welte, K. (2000). "Management of kostmann syndrome in the g-csf era." British Journal of Haematology 109(3): 490-495. <http://hdl.handle.net/2027.42/74012>en_US
dc.identifier.issn0007-1048en_US
dc.identifier.issn1365-2141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74012
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10886193&dopt=citationen_US
dc.format.extent250315 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsBlackwell Science Ltden_US
dc.subject.otherSevere Chronic Neutropeniaen_US
dc.subject.otherCongenital Neutropeniaen_US
dc.subject.otherKostmann Syndromeen_US
dc.subject.otherG-CSF Treatmenten_US
dc.titleManagement of kostmann syndrome in the g-csf eraen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, MI, USA,en_US
dc.contributor.affiliationotherMedizinische Hochschule, Hannover, Germany,en_US
dc.contributor.affiliationotherUniversity of Washington, Seattle, WA, USA,en_US
dc.contributor.affiliationotherHospital for Sick Children, Toronto, Ontario, Canada, anden_US
dc.contributor.affiliationotherYorkshire Regional Centre, West Yorkshire, UKen_US
dc.identifier.pmid10886193en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74012/1/j.1365-2141.2000.02064.x.pdf
dc.identifier.doi10.1046/j.1365-2141.2000.02064.xen_US
dc.identifier.sourceBritish Journal of Haematologyen_US
dc.identifier.citedreferenceAggett, P.J., Cavanagh, N.P.C., Matthew, D.J., Pincott, J.R., Sutcliffe, J., Harries, J.T. ( 1980 ) Shwachman's syndrome. Archives of Diseases in Childhood, 55, 331 347.en_US
dc.identifier.citedreferenceAnnabi, B., Hiraiwa, H., Mansfield, B.C., Lei, K.J., Ubagai, T., Polymeropoulos, M.H., Moses, S.W., Parvari, R., Hrshkovitz, E., Mandel, H., Fryman, M., Chou, J.Y. ( 1998 ) The gene for glycogen-storage disease type 1b maps to chromosome 11q23. American Journal of Human Genetics, 62, 400 405.en_US
dc.identifier.citedreferenceBarrett, A.J., Griscelli, C., Buriot, D., Faille, A. ( 1977 ) Lithium therapy in congenital neutropenia. Lancet, 2, 1357 1358.en_US
dc.identifier.citedreferenceBernard, T., Gale, R., Evans, J., Linch, D.C. ( 1998 ) Mutations of the granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. British Journal of Haematology, 101, 141 149.en_US
dc.identifier.citedreferenceBonilla, M., Gillio, A., Ruggeiro, M., Kernan, N., Brochstein, J., Abboud, M., Fumagalli, L., Vincent, M., Gabrilove, J., Welte, K., Souza, L., O'reilly, R. ( 1989 ) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New England Journal of Medicine, 320, 1574 1580.en_US
dc.identifier.citedreferenceBonilla, M., Dale, D., Zeidler, C., Last, L., Reiter, A., Ruggeiro, M., Davis, M., Koci, B., Hammond, W., Gillio, A., Welte, K. ( 1994 ) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congential neutropenias. British Journal of Haematology, 88, 723 730.en_US
dc.identifier.citedreferenceBux, J., Behrens, G., Jaeger, G., Welte, K. ( 1998 ) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood, 91, 181 186.en_US
dc.identifier.citedreferenceDale, D., Bonilla, M., Davis, M., Nakanishi, A., Hammond, W., Kurtzberg, J., Wang, W., Jakubowski, A., Winton, E., Lalezari, P., Robinson, W., Glapsy, J., Emerson, S., Gabrilove, J., Vincent, M., Boxer, L. ( 1993 ) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood, 81, 2496 2502.en_US
dc.identifier.citedreferenceDale, D.C. & Hammond, W. ( 1988 ) Cyclic neutropenia: a clinical review. Blood Review, 2, 178 185.en_US
dc.identifier.citedreferenceDong, F., Russel, K.B., Tidow, N., Welte, K., LÖwenberg, B., Touw, I.P. ( 1995 ) Mutations in the gene for the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New England Journal of Medicine, 333, 487 493.en_US
dc.identifier.citedreferenceFreedman, M.H. ( 1997 ) Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Current Opinion in Hematology, 4, 217 224.en_US
dc.identifier.citedreferenceGermeshausen, M., Tidow, N., Pilz, C., Tschan, C., Zeidler, C., Welte, K. ( 1999 ) G-CSF receptor mutations in patients with severe congenital neutropenia: frequency and implications in leukemic development (Abstract). Blood, 94, 45a.en_US
dc.identifier.citedreferenceGilman, P., Jackson, D., Guild, H. ( 1970 ) Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood, 36, 576 585.en_US
dc.identifier.citedreferenceGinzberg, H., Shin, J., Ellis, L., Morrison, J., Ip, W., Dror, Y., Freedman, M., Heitlinger, L.A., Bell, M.A., Corey, M., Rommens, J.M., Durie, P.R. ( 1999 ) Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. Journal of Pediatrics, 135, 81 88.en_US
dc.identifier.citedreferenceHammond, W.P., Price, T.H., Souza, L.M., Dale, D.C. ( 1989 ) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. New England Journal of Medicine, 320, 1306 1311.en_US
dc.identifier.citedreferenceHraker, W.G., Rothstein, G., Clarkson, D., Athens, J.W., Macfarlene, J.L. ( 1977 ) Enhancement of colony-stimulating activity production by lithium. Blood, 49, 263 267.en_US
dc.identifier.citedreferenceKostmann, R. ( 1956 ) Infantile genetic agranulocytosis. Acta Pediatrica Scandinavica, 45, 1 78.en_US
dc.identifier.citedreferenceKostmann, R. ( 1975 ) Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Pediatrica Scandinavica, 64, 362 368.en_US
dc.identifier.citedreferenceKyas, U., Pietsch, T., Welte, K. ( 1992 ) Expression of receptors for granulocyte-colony stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. Blood, 79, 1144 1147.en_US
dc.identifier.citedreferenceMcCawley, L.J., Korchak, H.M., Douglas, S.D., Campbell, D.E., Thornton, P.S., Stanley, C.A., Baker, L., Kilpatrick, L. ( 1994 ) In vitro and in vivo effects of granulocyte-stimulating factor on neutrophils in glycogen storage disease type 1b: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca 2+ mobilization. Pediatrics Research, 35, 84 90.en_US
dc.identifier.citedreferenceMempel, K., Pietsch, T., Menzel, T., Zeidler, C., Welte, K. ( 1991 ) Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood, 77, 1919 1922.en_US
dc.identifier.citedreferenceMorley, A.A., Carew, J.P., Baikie, A.G. ( 1967 ) Familial cyclic neutropenia. British Journal of Haematology, 13, 719 737.en_US
dc.identifier.citedreferenceNagata, S., Tsuchiya, M., Asano, S., Kaziro, Y., Yamazaki, T., Yamamoto, O., Hirata, Y., Kubota, N., Oheda, M., Nomura, H., Ono, M. ( 1986 ) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature, 319, 415 418.en_US
dc.identifier.citedreferenceQuesenberry, P.J. ( 1983 ) Cyclic hematopoiesis: disorders of primitive hematopoietic stem cells. Experimental Hematology, 11, 687 700.en_US
dc.identifier.citedreferenceRappeport, J., Parkman, R., Newburger, P., Camitta, B., Chusid, M. ( 1980 ) Correction of infantile agranulocytosis (Kostmann syndrome) by allogeneic bone marrow transplantation. American Journal of Medicine, 68, 605 609.en_US
dc.identifier.citedreferenceRosen, R. & Kang, S. ( 1979 ) Congenital agranulocytosis terminating in acute myelomonocytic leukemia. Journal of Pediatrics, 94, 406 408.en_US
dc.identifier.citedreferenceSchroten, H., Roesler, J., Breidenbach, T., Wendel, U., Elsner, J., Schweitzer, S., Zeidler, C., Burdach, S.T., Lohmann-Matthes, M.L., Wahn, V., Welte, K. ( 1991 ) G-CSF and GM-CSF for treatment of neutropenia in glycogen storage disease type 1b. Journal of Pediatrics, 119, 748 754.en_US
dc.identifier.citedreferenceSmith, O.P., Hann, I.M., Chessels, J.M., Reeves, B.R., Milla, P. ( 1996 ) Haematological abnormalities in Shwachman–Diamond syndrome. British Journal of Haematology, 94, 279 284.en_US
dc.identifier.citedreferenceSouza, L., Boone, T., Gabrilove, J., Lai, P.H., Zsebo, K.M., Murdock, D.C., Chazin, V.R., Bruszewski, J., Lu, H., Chen, K.K., Barendt, J., Platzer, E., Moore, M.A.S., Mertelsmann, R., Welte, K. ( 1986 ) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science, 232, 61 65.en_US
dc.identifier.citedreferenceTidow, N., Pilz, C., Teichmann, B., MÜller-Brechlin, A., Germeshausen, M., Kasper, B., Rauprich, P., Sykora, K.-W., Welte, K. ( 1997 ) Clinical relevance of point mutations in the cytoplasmatic domain of the granulocyte-colony stimulating factor gene in patients with severe congenital neutropenia. Blood, 88, 2369 2375.en_US
dc.identifier.citedreferenceWelte, K. & Boxer, L. ( 1997 ) Severe chronic neutropenia: pathophysiology and therapy. Seminars in Hematology, 34, 267 278.en_US
dc.identifier.citedreferenceWelte, K. & Dale, D. ( 1996 ) Pathophysiology and treatment of severe chronic neutropenia. Annals of Hematology, 72, 158 165.en_US
dc.identifier.citedreferenceWelte, K., Zeidler, C., Reiter, A., Odenwald, E., Souza, L., Riehm, H. ( 1990 ) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood, 75, 1056 1063.en_US
dc.identifier.citedreferenceYakisan, E., Schirg, E., Zeidler, C., Bishop, N.J., Reiter, A., Hirt, A., Riehm, H., Welte, K. ( 1997 ) High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). Journal of Pediatrics, 131, 592 597.en_US
dc.identifier.citedreferenceZeidler, C., Vogel, R., Wyres, M., Welte, K. ( 1998 ) Beneficial effects of stem cell factor (SCF) in children with severe congenital neutropenias refractory to G-CSF (Abstract). Blood, 92, 380a.en_US
dc.identifier.citedreferenceZeidler, C., Welte, K., Barak, Y., Barriga, F., Bolyard, A.A., Boxer, L., Cornu, G., Cowan, M.J., Dale, D.C., Flood, T., Freedman, M., Gadner, H., Mandel, H., O'reilly, R.J., Ramenghi, U., Reiter, A., Skinner, R., Vermylen, C., Levine, J.E. ( 2000 ) Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood, 95, 1195 1198.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2141.2000.02064.x.pdf
Size:
244.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.